PathoVax Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 11

PathoVax General Information

Description

Developer of an HPV vaccine designed to combat the infectious disease. The company's product is developed and commercialized as a broad-spectrum vaccine for the treatment of human papillomavirus, enabling users to get cured of the infectious disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • 1812 Ashland Avenue
  • Suite 100
  • Baltimore, MD
  • United States

PathoVax Timeline

2018201920202021
Financing RoundFinancing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PathoVax Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Accelerator/Incubator 21-May-2019 00.000 Completed Generating Revenue
11. Corporate 30-Aug-2018 00.000 00.000 Completed Startup
10. Grant 01-Jan-2018 00000 00.000 Completed Startup
9. Grant 21-Dec-2017 00000 00.000 Completed Startup
8. Grant 18-Sep-2017 00000 00.000 Completed Startup
7. Accelerator/Incubator 28-Oct-2016 00000 00.000 Completed Startup
6. Angel (individual) 24-May-2016 00000 00000 Completed Startup
5. Accelerator/Incubator 04-Apr-2016 Completed Startup
4. Accelerator/Incubator 15-Jan-2016 Completed Startup
3. Grant 01-Jul-2015 $100K Completed Startup
To view PathoVax’s complete valuation and funding history, request access »

PathoVax Executive Team (4)

Name Title Board Seat Contact Info
Joshua Wang Ph.D Co-Founder, Chief Executive Officer & Board Member
Nicholas Calcaterra Ph.D Co-Founder & Interim Chief Financial Officer
You’re viewing 2 of 4 executive team members. Get the full list »

PathoVax Board Members (1)

Name Representing Role Since
Joshua Wang Ph.D PathoVax Co-Founder, Chief Executive Officer & Board Member 000 0000
To view PathoVax’s complete board members history, request access »

PathoVax Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
JLABS Accelerator/Incubator 000 0000 000000 0
United Heath Investments Corporation Minority 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
National Institutes of Allergy and Infectious Disease Government 000 0000 000000 0
National Cancer Institute Government 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »